Although upregulation of TGF-β in peripheral blood were suggested to be mediated by either tumour or tumour stromal cells, our findings indicated that tumour-platelet interaction as a new potential source for the increased levels of these factors in blood. Here, TGFB1 is linked to neoplasm.